Hints and tips:
...It follows Lauren’s co-founding of the Nina Hyde Centre for Breast Cancer Research in 1989, among other causes geared toward cancer research and treatment throughout his career....
...“a very minimal 1 per cent drag” on earnings per share for S&P 500 companies....
...Lacks had cervical cancer, which was to kill her within months at the age of 31....
...in Latin America....
...The opioid epidemic has shaped America....
...stakes in professional sports teams....
...“When you call in with something like cancer or stress, in a discreet and professional way the firm will respond,” he says....
...“Gene therapy gives our cells the genetic capability they need to repair the illness themselves,” explains Dr Michel Sadelain, an expert in gene therapy at Memorial Sloan Kettering Cancer Center in New York...
...The market is dominated by two companies, Laboratory Corporation of America and Quest; together, they had sales of almost $16bn and gross profits of $5.7bn last year....
...During her final hours she called her mother after she was shot, screaming that she was losing a lot of blood. Jean C....
...Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York, says Mr Shkreli’s aggressive approach is the natural consequence of a US system that...
...She tried two courses of treatment, both of which failed. By 2003, she had to face up to the possibility that she would die from hepatitis C, which can lead to cirrhosis and liver cancer....
...Express Scripts, which negotiates with drug companies on behalf of many insurers, has led a push to force cuts in the price of hepatitis C treatments by shutting out higher-priced products....
...Last year’s high-profile backlash by US insurers and politicians against the price of new breakthrough treatments for hepatitis C — particularly Gilead Sciences’ $1,000-a-day Sovaldi — suggests that America...
...By introducing them to the arts, he says he can help cure the “cancer of the spirit” that still sickens so much of inner-city America....
...Prior to becoming dean at Sloan in 2007, Prof Schmittlein was deputy dean of the Wharton School at the University of Pennsylvania....
...They included big names from the hedge fund industry – Julian Robertson of Tiger Management and Paul Singer of Elliott Management Corporation....
...Today, the discoveries taking place in our federally-financed labs and universities could lead to new treatments that kill cancer cells but leave healthy ones untouched....
...The S&P 500 finished the day at 1,257.81, on solid gains of 0.5 per cent....
...After four years of joint development with Syneron, P&G’s business in Canada has started selling its Olay Professional ReFirme treatment for C$250 (US$248)....
...As I investigated the causes and patterns of wilful blindness, from our daily lives to the boardrooms of global corporations, I could have confined myself to corporations alone; there’s no shortage of material...
...Mr Tauzin, a cancer survivor, has said his retirement was planned....
...Last year, we made the largest investment in basic research funding in history – an investment that could lead to the world’s cheapest solar cells or treatment that kills cancer cells but leaves healthy...
...Mothers share their experiences using P&G’s new products with members of their social circle, typically 20 to 25 moms....
...As Paul Schervish, director of the Boston College Center on Wealth and Philanthropy puts it: “These organisations aren’t sexy.”...
International Edition